2012
DOI: 10.1371/journal.pone.0035104
|View full text |Cite
|
Sign up to set email alerts
|

Rational Incorporation of Selenium into Temozolomide Elicits Superior Antitumor Activity Associated with Both Apoptotic and Autophagic Cell Death

Abstract: Background The DNA alkylating agent temozolomide (TMZ) is widely used in the treatment of human malignancies such as glioma and melanoma. On the basis of previous structure-activity studies, we recently synthesized a new TMZ selenium analog by rationally introducing an N -ethylselenocyanate extension to the amide functionality in TMZ structure. Principal Findings This TMZ-Se analog showed a superior cytotoxicity to TMZ in human glioma and mela… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
30
0

Year Published

2014
2014
2020
2020

Publication Types

Select...
8
1
1

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(31 citation statements)
references
References 25 publications
1
30
0
Order By: Relevance
“…Thus, the dynamics of these structures are essential in normal cell physiology [3739]. For this reason, a variety of antitumor agents with action on microtubules have been developed [20].…”
Section: Discussionmentioning
confidence: 99%
“…Thus, the dynamics of these structures are essential in normal cell physiology [3739]. For this reason, a variety of antitumor agents with action on microtubules have been developed [20].…”
Section: Discussionmentioning
confidence: 99%
“…42,51,52 To our knowledge, only one derivative has outperformed TMZ in an intracranial murine model of GBM, bestowing a modest 10% increase in median survival. 53 Clearly, the interplay between retaining the favorable properties that have kept TMZ as frontline treatment for GBM and modulating its structure is not trivial.…”
Section: Resultsmentioning
confidence: 88%
“…TMZ, the first-line chemotherapeutic drug for GBM treatment, causes cancer cell death by inducing DNA double strand breaks [36, 37], but the human glioblastoma cell line LN229 has a high degree of resistance to TMZ [38, 39]. In the orthotopic xenograft mouse model, compared with the TMZ and siPSMB4 groups, the combination of TMZ-siPSMB4 group inhibited the progression of GBM tumors.…”
Section: Discussionmentioning
confidence: 99%